|
MTM1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.93059999600942E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.24069999829501E-08 |
| Normal-vs-Stage2 |
9.276200E-02 |
| Normal-vs-Stage3 |
1.158720E-04 |
| Normal-vs-Stage4 |
4.79909999517858E-08 |
| Stage1-vs-Stage2 |
2.306200E-01 |
| Stage1-vs-Stage3 |
9.653800E-01 |
| Stage1-vs-Stage4 |
6.752200E-02 |
| Stage2-vs-Stage3 |
2.706800E-01 |
| Stage2-vs-Stage4 |
1.166060E-02 |
| Stage3-vs-Stage4 |
8.594300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.4881999965688E-08 |
| Normal-vs-AfricanAmerican |
3.81390000003812E-06 |
| Normal-vs-Asian |
2.172400E-01 |
| Caucasian-vs-AfricanAmerican |
7.373600E-01 |
| Caucasian-vs-Asian |
8.923400E-01 |
| AfricanAmerican-vs-Asian |
9.881600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.68190003538393E-09 |
| Normal-vs-Female |
1.023460E-03 |
| Male-vs-Female |
1.066310E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.49550000009214E-07 |
| Normal-vs-Extreme_Weight |
1.12599995993889E-09 |
| Normal-vs-Obese |
1.006500E-04 |
| Normal-vs-Extreme_Obese |
4.007300E-04 |
| Normal_Weight-vs-Extreme_Weight |
7.044400E-01 |
| Normal_Weight-vs-Obese |
1.606040E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.341200E-01 |
| Extreme_Weight-vs-Obese |
3.892000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.415400E-01 |
| Obese-vs-Extreme_Obese |
5.343800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.21039999981754E-07 |
| Normal-vs-Age(41-60Yrs) |
4.33460000004438E-07 |
| Normal-vs-Age(61-80Yrs) |
2.46519999969053E-08 |
| Normal-vs-Age(81-100Yrs) |
3.915500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.092200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.808800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.089200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.756200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.363600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.763000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.17970000049306E-07 |
| Normal-VS-Type2 PRCC |
4.08560000000335E-05 |
| Normal-VS-KIRP CIMP |
9.4918000015376E-08 |
| Normal-VS-Unclassified PRCC |
6.155200E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.164200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.159800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.830160E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.840100E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
6.202800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.619300E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.55510000046755E-07 |
| Normal-vs-N1 |
3.51469999992915E-07 |
| Normal-vs-N2 |
6.15659999999574E-05 |
| N0-vs-N1 |
6.253400E-01 |
| N0-vs-N2 |
2.179200E-01 |
| N1-vs-N2 |
2.869200E-01 |
|
|
